1. Gregorio Marañon General University Hospital. Madrid. Spain.
EXPERIENCE WITH THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD (BVS) IN VARIOUS SCENARIOS OF CONGENITAL HEART DISEASE
A. Rodríguez Ogando, F. Ballesteros Tejerizo, R. Perez Caballero, M. González López, T. Álvarez, M. Camino, R. Alvarez García-Roves, N. Gil Villanueva, C. Medrano López, JL. Zunzunegui Martínez
Gregorio Marañon General University Hospital. Madrid. Spain.

2. METHODS: BACKGROUND: OBJECTIVE:
Children outgrow metal stents, obligating them to future transcatheter dilations and eventual surgical removal. A bioabsorbable stent, or a stent that goes away with time, would solve this problem.
Describe our experience with BVS in the
setting of different vascular lesions in CHD
Clinical records, catheterization data, and operation notes of eight consecutive patients undergoing BVS implantation since July- 2013 were studied retrospectively
BACKGROUND:
OBJECTIVE:
METHODS:

3. RESULTS: The patient´s median age was 3,8 months
(10 days-6,3 years) and the median weight was 3,95 kg (1,5-48).
Carotid

4. RESULTS: The angiographic result was satisfactory in all cases.
No related complications and non acute obstruction were observed.
Four patients underwent cardiac surgery. At the time of surgery, stent structure was not found by the surgeon, and procedure was carried out without any difficulty

5. CONCLUSIONS:
Considering advances in percutaneous treatment of CHD, the biodegradable stents are already a reality, and BVS stenting is a reliable and safe alternative to angioplasty, metal stents, or surgical approach in selected patients.